Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125924921 | 12592492 | 1 | I | 20160722 | 20160726 | 20160726 | EXP | PH-ROCHE-1801062 | ROCHE | 0.00 | F | Y | 0.00000 | 20160726 | MD | PH | PH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125924921 | 12592492 | 1 | PS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | 103705 | 80 | MG | SOLUTION FOR INFUSION | |||||||
| 125924921 | 12592492 | 2 | SS | MABTHERA | RITUXIMAB | 1 | U | 103705 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125924921 | 12592492 | 1 | Diffuse large B-cell lymphoma |
| 125924921 | 12592492 | 2 | Metastases to liver |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125924921 | 12592492 | OT |
| 125924921 | 12592492 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125924921 | 12592492 | Hepatic function abnormal | |
| 125924921 | 12592492 | Hepatitis B surface antigen positive | |
| 125924921 | 12592492 | Jaundice | |
| 125924921 | 12592492 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |